Cargando…

Role of E-type prostaglandin receptor EP3 in the vasoconstrictor activity evoked by prostacyclin in thromboxane-prostanoid receptor deficient mice

Prostacyclin, also termed as prostaglandin I(2) (PGI(2)), evokes contraction in vessels with limited expression of the prostacyclin receptor. Although the thromboxane-prostanoid receptor (TP) is proposed to mediate such a response of PGI(2), other unknown receptor(s) might also be involved. TP knock...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhenhua, Zhang, Yingzhan, Liu, Bin, Luo, Wenhong, Li, Hui, Zhou, Yingbi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292700/ https://www.ncbi.nlm.nih.gov/pubmed/28165064 http://dx.doi.org/10.1038/srep42167

Ejemplares similares

Increased role of E prostanoid receptor-3 in prostacyclin-evoked contractile activity of spontaneously hypertensive rat mesenteric resistance arteries
por: Liu, Bin, et al.
Publicado: (2017)

Vasomotor Reaction to Cyclooxygenase-1-Mediated Prostacyclin Synthesis in Carotid Arteries from Two-Kidney-One-Clip Hypertensive Mice
por: Liu, Bin, et al.
Publicado: (2015)

The role of thromboxane prostanoid receptor signaling in gastric ulcer healing
por: Yamane, Sakiko, et al.
Publicado: (2021)

Antagonism of the Thromboxane‐Prostanoid Receptor as a Potential Therapy for Cardiomyopathy of Muscular Dystrophy
por: West, James D., et al.
Publicado: (2019)

Prostaglandin E(2) Prevents Hyperosmolar-Induced Human Mast Cell Activation through Prostanoid Receptors EP(2) and EP(4)
por: Torres-Atencio, Ivonne, et al.
Publicado: (2014)

Prostacyclin and thromboxane in benign and malignant breast tumours.
por: Laekeman, G. M., et al.
Publicado: (1986)

Expression of prostaglandin E(2) prostanoid receptor EP2 and interleukin-1β in laryngeal carcinoma – preliminary study
por: Mochocki, Marcin, et al.
Publicado: (2015)

Prostacyclin and thromboxane in breast cancer: relationship between steroid receptor status and medroxyprogesterone acetate.
por: Aitokallio-Tallberg, A., et al.
Publicado: (1985)

E-type prostanoid receptor 4 (EP4) in disease and therapy
por: Konya, Viktoria, et al.
Publicado: (2013)

Full and Partial Agonists of Thromboxane Prostanoid Receptor Unveil Fine Tuning of Receptor Superactive Conformation and G Protein Activation
por: Capra, Valérie, et al.
Publicado: (2013)

Contribution of prostanoid FP receptor and prostaglandins in transient inflammatory ocular hypertension
por: Yamagishi-Kimura, Reiko, et al.
Publicado: (2018)

Oxidized Low-Density Lipoprotein Suppresses Expression of Prostaglandin E Receptor Subtype EP3 in Human THP-1 Macrophages
por: Sui, Xuxia, et al.
Publicado: (2014)

The pharmacological effect of BGC20-1531, a novel prostanoid EP(4) receptor antagonist, in the Prostaglandin E(2) human model of headache
por: Antonova, Maria, et al.
Publicado: (2011)

Improved homology modeling of the human & rat EP(4) prostanoid receptors
por: Holt, Melissa C., et al.
Publicado: (2019)

Prostacyclin, thromboxane and glomerular filtration rate are abnormal in sickle cell pregnancy
por: Obilade, Opeyemi Abayomi, et al.
Publicado: (2017)

EP3 Blockade Adds to the Effect of TP Deficiency in Alleviating Endothelial Dysfunction in Atherosclerotic Mouse Aortas
por: Hu, Chuangjia, et al.
Publicado: (2019)

The Gαs‐protein‐mediated pathway may be steadily stimulated by prostanoid EP2 receptors, but not by EP4 receptors
por: Fukushima, Keijo, et al.
Publicado: (2022)

A strategy using NMR peptide structures of thromboxane A2 receptor as templates to construct ligand-recognition pocket of prostacyclin receptor
por: Ruan, Cheng-Huai, et al.
Publicado: (2005)

Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation
por: Philipose, Sonia, et al.
Publicado: (2012)

Laropiprant attenuates EP(3) and TP prostanoid receptor-mediated thrombus formation
por: Philipose, Sonia, et al.
Publicado: (2012)

Expression of the TPα and TPβ isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer: clinical significance and diagnostic potential
por: Mulvaney, Eamon P., et al.
Publicado: (2016)

Differential effects of oral and transdermal menopausal hormone therapy on prostacyclin and thromboxane in platelets
por: Raz, Limor, et al.
Publicado: (2014)

Rat prostaglandin EP3 receptor is highly promiscuous and is the sole prostanoid receptor family member that regulates INS‐1 (832/3) cell glucose‐stimulated insulin secretion
por: Sandhu, Harpreet K., et al.
Publicado: (2021)

Prostacyclin-IP signaling and prostaglandin E(2)-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis
por: Honda, Tetsuya, et al.
Publicado: (2006)

Elevated Ratio of Urinary Metabolites of Thromboxane and Prostacyclin Is Associated with Adverse Cardiovascular Events in ADAPT
por: Montine, Thomas J., et al.
Publicado: (2010)

Activity of the cyclooxygenase 2-prostaglandin-E prostanoid receptor pathway in mice exposed to house dust mite aeroallergens, and impact of exogenous prostaglandin E(2)
por: Herrerias, Aida, et al.
Publicado: (2009)

Uridine Adenosine Tetraphosphate-Induced Coronary Relaxation Is Blunted in Swine With Pressure Overload: A Role for Vasoconstrictor Prostanoids
por: Zhou, Zhichao, et al.
Publicado: (2018)

Thromboxane prostanoid signaling in macrophages attenuates lymphedema and facilitates lymphangiogenesis in mice: TP signaling and lymphangiogenesis
por: Mishima, Toshiaki, et al.
Publicado: (2023)

The affinity, intrinsic activity and selectivity of a structurally novel EP(2) receptor agonist at human prostanoid receptors
por: Coleman, R A, et al.
Publicado: (2019)

Physiology and pathophysiology of prostanoid receptors
por: Narumiya, Shuh
Publicado: (2007)

Expression of Prostanoid EP3 Receptors in Oral Squamous Epithelium and Oral Squamous Cell Carcinoma
por: Kashif, Muhammad, et al.
Publicado: (2015)

Expression of prostaglandin I2 (prostacyclin) receptor in blood of migraine patients: A potential biomarker
por: Kheirollahi, Majid, et al.
Publicado: (2015)

Heterodimerization of the prostaglandin E2 receptor EP2 and the calcitonin receptor CTR
por: Matsubara, Shin, et al.
Publicado: (2017)

International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E(2) Receptors (EP1–4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions
por: Norel, Xavier, et al.
Publicado: (2020)

Role of the prostaglandin E2/E-prostanoid 2 receptor signalling pathway in TGFβ-induced mice mesangial cell damage
por: Li, Na-Na, et al.
Publicado: (2014)

Urinary excretion of prostacyclin and thromboxane degradation products in patients with ovarian malignancy: effect of cytostatic treatment.
por: Aitokallio-Tallberg, A., et al.
Publicado: (1989)

Ca(2+) signals evoked by histamine H(1) receptors are attenuated by activation of prostaglandin EP(2) and EP(4) receptors in human aortic smooth muscle cells
por: Pantazaka, Evangelia, et al.
Publicado: (2013)

Niacin ameliorates ulcerative colitis via prostaglandin D(2)‐mediated D prostanoid receptor 1 activation
por: Li, Juanjuan, et al.
Publicado: (2017)

Cloning and expression of the rabbit prostaglandin EP2 receptor
por: Guan, Youfei, et al.
Publicado: (2002)

The role of the EP receptors for prostaglandin E(2) in skin and skin cancer
por: Rundhaug, J. E., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_gg6drocbl7v699qjtrkmob2f45